Prostate cancer (PCa) is traditionally diagnosed via digital rectal inspection (DRE) and a prostate-specific antigen (PSA) test, followed by transrectal ultrasound (TRUS)-guided biopsy [1]. This evidence concerns the gene KLK3 and prostate cancer.